Home>Topics>>Incyte Pharmaceuticals Is Primed For A Run
Incyte Pharmaceuticals Is Primed For A Run
Healthcare Sector and Stocks Analysis from Seeking Alpha
Tue, 5 Feb 2013
By Alpha Cardinal : By Paul Jaschke, Ph.D., Ju Lu Ph.D., Widya Mulyasasmita and Luke J. Lee Incyte Pharmaceuticals ( INCY ) is focused on discovering, developing, and commercializing novel small molecule drugs for serious, unmet oncology and inflammatory diseases and needs. They won approval for ...
Independent. Insightful. Trusted. Morningstar provides stock market analysis; equity, mutual fund, and ETF research, ratings, and picks; portfolio tools; and option, hedge fund, IRA, 401k, and 529 plan research. Our reliable data and analysis can help both experienced enthusiasts and newcomers.